Search

Author/Creator Tan, Beesan

1. A 4-week study assessing the pharmacokinetics, pharmacodynamics, safety, and tolerability of the glucagon receptor antagonist PF-06291874 administered as monotherapy in subjects with type 2 diabetes mellitus. (April 2017)

Authors:
Bergman, Arthur; Tan, Beesan; Somayaji, Veena R.; Calle, Roberto A.; Kazierad, David J.
Journal:
Diabetes research and clinical practice
Issue:
Volume 126(2017)
Page Start:
95
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PF‐04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo‐Controlled Study. Issue 2 (31st December 2018)

Authors:
Charnigo, Robert J.; Beidler, David; Rybin, Denis; Pittman, Debra D.; Tan, Beesan; Howard, Jo; Michelson, Alan D.; Frelinger, Andrew L.; Clarke, Nicholas
Journal:
Clinical and translational science
Issue:
Volume 12:Issue 2(2019)
Page Start:
180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗